Ledger.Open graph →
SEC Form D · Amendment · filed February 1, 2022

Epicore Biosystems, Inc

Offering
$10.0M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Roozbeh Ghaffari · CAMBRIDGE, MAExec · DirectorJohn Rogers · CAMBRIDGE, MADirectorSirshendu R. Banerjee · Woburn, MADirectorMichael G. Campbell · Woburn, MAExec · DirectorJames N. Moore · Santa Monica, CAExec · DirectorThomas W. Mazza · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗